Renal fibrosis in mice treated with human recombinant transforming growth factor-β2

This publication has 36 references indexed in Scilit:

• TRANSFORMING GROWTH FACTOR (TGF)-?? MIMICS AND ANTI-TGF-?? ANTIBODY ABROGATES THE IN VIVO EFFECTS OF CYCLOSPORINE
  Transplantation, 1999
• Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis
  American Journal of Kidney Diseases, 1998
• Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
  Hypertension, 1998
• The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunity
  Immunology Today, 1997
• Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.
  The Journal of Experimental Medicine, 1994
• Transforming growth factor‐β2 induces apoptosis of murine T cell clones without down‐regulating bcl‐2 mRNA expression
  European Journal of Immunology, 1994
• Site specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporine
  Kidney International, 1994
• Gene Expression in Low Oxygen Tension
  The Lancet Healthy Longevity, 1993
• Cardioprotective actions of transforming growth factor-β
  Trends in Cardiovascular Medicine, 1993
• Growth Inhibitory Effects of Transforming Growth Factor-β1 in vivo
  Growth Factors, 1991